Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 386 views
Type at least 3 characters
16 articles
Articles
Review
Published on 19 Dec 2024
Targeting steroid receptor coactivators in cancer via small molecule agents
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1514412
- 306 views
Review
Published on 30 Sep 2024
Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1465222
- 794 views
Correction
Published on 17 Apr 2024
Corrigendum: Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1397200
- 592 views
Original Research
Published on 11 Apr 2024
A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1278163
- 1,804 views
Review
Published on 11 Apr 2024
A review on dynamics of permeability-glycoprotein in efflux of chemotherapeutic drugs
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1363364
- 1,607 views
- 1 citation
Editorial
Published on 07 Feb 2024
Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1365318
- 834 views
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 2,546 views
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 3,551 views
- 3 citations
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 1,219 views
Original Research
Published on 09 May 2023
Generation of a potent anti-PD-L1-CD47 bispecific antibody with a strong therapeutic and safety profile for cancer immunotherapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1182146
- 3,838 views
- 1 citation
Review
Published on 06 Dec 2022
Coumarin-1,2,3-triazole hybrids as leading-edge anticancer agents
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1072448
- 3,971 views
- 13 citations
Original Research
Published on 29 Nov 2022
ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1050687
- 1,961 views
Clinical Trial
Published on 09 Sep 2022
Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.963045
- 1,880 views
Brief Research Report
Published on 10 Aug 2022
Stemness inhibition by (+)-JQ1 in canine and human mammary cancer cells revealed by machine learning
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.953988
- 3,093 views
- 2 citations
Mini Review
Published on 10 Mar 2022
A Mini-Review of the Anticancer Properties of Cryptotanshinone: A Quinoid Diterpene Extracted From the Root of Salvia miotiorrhiza Bunge
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.815017
- 2,819 views
- 4 citations